Literature DB >> 35179677

3H-1,2-dithiole-3-thione suppresses LPS-induced proinflammatory responses in macrophages: potential involvement of antioxidant induction, NF-κB, and Nrf2.

Hong Zhu1, An Bui2, Arben Santo3, Y Robert Li2.   

Abstract

Previously, we reported that 3H-1,2-dithiole-3-thione (D3T), an Nrf2 activator, acted as a potential chemoprotectant against lipopolysaccharide (LPS)-induced mortality in mice. In view of the critical involvement of macrophages in the pathogenesis of LPS-induced endotoxemia, in the present study, we investigated the protective effects of D3T on LPS-induced proinflammatory responses in cultured murine RAW 264.7 macrophage cell line and primary peritoneal macrophages and the potential involvement of antioxidant induction, NF-κB, and Nrf2. We showed that treatment with D3T resulted in increased levels of a series of antioxidants in RAW 264.7 cells in a concentration-dependent manner. These included the reduced form of glutathione, glutathione peroxidase, glutathione reductase, glutathione S-transferase, and NADPH:quinone oxidoreductase 1. Catalase was also potently induced by D3T which, however, did not show a concentration dependency. Concurrent with the ability to induce the above cellular antioxidants, D3T pretreatment of RAW 264.7 cells also led to a concentration-dependent suppression of LPS-induced interleukin-1beta (IL-1β) production and nitric oxide release. LPS-stimulated tumor necrosis factor-alpha (TNF-α) production was also suppressed by D3T, but to a much lesser extent. Using NF-κB reporter gene-expressing RAW 264.7 cells, we further showed that D3T pretreatment also suppressed LPS-induced NF-κB activation. To investigate the potential involvement of Nrf2, a chief regulator of cellular antioxidant genes, we used peritoneal macrophages isolated from Nrf2+/+ and Nrf2-/- mice. Our results showed that D3T pretreatment suppressed LPS-induced proinflammatory responses in Nrf2+/+ macrophages, and this inhibitory effect of D3T was completely lost in Nrf2-/- macrophages. Collectively, the results of the present study demonstrated that D3T acted as a potent suppressor of LPS-induced proinflammatory responses in macrophages. Antioxidant induction, NF-κB suppression, and Nrf2 activation appeared to contribute to the anti-proinflammatory activity of D3T in macrophages.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  3H-1,2-Dithiole-3-thione; IL-1β; NF-κB; Nrf2; RAW 264.7 cells; TNF-α

Mesh:

Substances:

Year:  2022        PMID: 35179677      PMCID: PMC8989649          DOI: 10.1007/s11010-021-04331-x

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  31 in total

Review 1.  Sepsis: a roadmap for future research.

Authors:  Jonathan Cohen; Jean-Louis Vincent; Neill K J Adhikari; Flavia R Machado; Derek C Angus; Thierry Calandra; Katia Jaton; Stefano Giulieri; Julie Delaloye; Steven Opal; Kevin Tracey; Tom van der Poll; Eric Pelfrene
Journal:  Lancet Infect Dis       Date:  2015-04-19       Impact factor: 25.071

2.  Cruciferous dithiolethione-mediated coordinated induction of total cellular and mitochondrial antioxidants and phase 2 enzymes in human primary cardiomyocytes: cytoprotection against oxidative/electrophilic stress and doxorubicin toxicity.

Authors:  Hong Zhu; Zhenquan Jia; Kequan Zhou; Hara P Misra; Arben Santo; Kathleen L Gabrielson; Yunbo Li
Journal:  Exp Biol Med (Maywood)       Date:  2009-01-28

Review 3.  Septic Shock: Advances in Diagnosis and Treatment.

Authors:  Christopher W Seymour; Matthew R Rosengart
Journal:  JAMA       Date:  2015-08-18       Impact factor: 56.272

Review 4.  NF-kappa B activation as a pathological mechanism of septic shock and inflammation.

Authors:  Shu Fang Liu; Asrar B Malik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-04       Impact factor: 5.464

5.  The chemical inducibility of mouse cardiac antioxidants and phase 2 enzymes in vivo.

Authors:  Zhuoxiao Cao; Yunbo Li
Journal:  Biochem Biophys Res Commun       Date:  2004-05-14       Impact factor: 3.575

6.  Nuclear factor E2-related factor 2-dependent myocardiac cytoprotection against oxidative and electrophilic stress.

Authors:  Hong Zhu; Zhenquan Jia; Bhaba R Misra; Li Zhang; Zhuoxiao Cao; Masayuki Yamamoto; Michael A Trush; Hara P Misra; Yunbo Li
Journal:  Cardiovasc Toxicol       Date:  2008-05-08       Impact factor: 3.231

7.  The highly expressed and inducible endogenous NAD(P)H:quinone oxidoreductase 1 in cardiovascular cells acts as a potential superoxide scavenger.

Authors:  Hong Zhu; Zhenquan Jia; James E Mahaney; David Ross; Hara P Misra; Michael A Trush; Yunbo Li
Journal:  Cardiovasc Toxicol       Date:  2007       Impact factor: 3.231

8.  Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival.

Authors:  Mi-Kyoung Kwak; Nobunao Wakabayashi; Ken Itoh; Hozumi Motohashi; Masayuki Yamamoto; Thomas W Kensler
Journal:  J Biol Chem       Date:  2002-12-27       Impact factor: 5.157

9.  Lipopolysaccharide-induced expression of NAD(P)H:quinone oxidoreductase 1 and heme oxygenase-1 protects against excessive inflammatory responses in human monocytes.

Authors:  Stuart A Rushworth; David J MacEwan; Maria A O'Connell
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

10.  Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.

Authors:  Kristina E Rudd; Sarah Charlotte Johnson; Kareha M Agesa; Katya Anne Shackelford; Derrick Tsoi; Daniel Rhodes Kievlan; Danny V Colombara; Kevin S Ikuta; Niranjan Kissoon; Simon Finfer; Carolin Fleischmann-Struzek; Flavia R Machado; Konrad K Reinhart; Kathryn Rowan; Christopher W Seymour; R Scott Watson; T Eoin West; Fatima Marinho; Simon I Hay; Rafael Lozano; Alan D Lopez; Derek C Angus; Christopher J L Murray; Mohsen Naghavi
Journal:  Lancet       Date:  2020-01-18       Impact factor: 202.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.